In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify marijuana as a Plan III drug. This rescheduling will identify that cannabis has legitimate healthcare functions and should help open up the doorway to study on other likely treatment takes advantage o